RxDoctor Payments Data

Dorothy Clerici

Nurse Practitioner · Louisville, KYNPI 1205277654

Payments from drug & device makers

$8,805in general payments, 2019–2025

Across 488 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$940
  • Teva Pharmaceuticals USA, Inc.$933
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$829
  • Vanda Pharmaceuticals Inc.$781
  • Alkermes, Inc.$688
  • plus $3K from 16 others

What the payments were for

  • Food & beverage$8,74199%
  • Education$641%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,805 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole51$90,866
Invega SustennaPaliperidone Palmitate19$65,625
VraylarCariprazine Hcl46$65,390
AristadaAripiprazole Lauroxil15$47,855
Abilify MaintenaAripiprazole15$43,307
TrintellixVortioxetine Hydrobromide48$26,770
CaplytaLumateperone Tosylate13$24,515
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl135$14,609
Olanzapine60$6,247
Pregabalin12$4,098
Clomipramine Hcl23$2,701
Aripiprazole39$1,917
Buspirone Hcl78$1,389
Duloxetine Hcl69$751
Vilazodone Hcl18$745

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$940$134,17366 claims
Johnson & JohnsonInvega Sustenna$154$65,62519 claims
AbbVieVraylar$1,701$65,39046 claims
Alkermes, Inc.Aristada$688$47,85515 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$207$26,77048 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$829$24,51513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →